Patents by Inventor Yuqin Jiang

Yuqin Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12291516
    Abstract: Disclosed is a compound of formula I or a pharmaceutically acceptable salt, active metabolite, tautomer, stereoisomer, or prodrug thereof as BTK (Bruton's Tyrosine Kinase) inhibitors, which is useful for the treatment of autoimmune disease, inflammatory disease, cancer and potentially allergies.
    Type: Grant
    Filed: May 9, 2020
    Date of Patent: May 6, 2025
    Assignee: Henan Zhiwei Biomedicine Co., Ltd.
    Inventors: Qingjie Ding, Chunhua Ma, Yuqin Jiang, Guiqing Xu, Wei Li, Minghao Zhao, Qingyun Li, Dandan Zhang, Guojie Fan, Yang Li, Xin Shi, Shouning Yang
  • Publication number: 20240130071
    Abstract: An outdoor electric cabinet and an air duct structure thereof are provided. The air duct structure is used to guide airflow to an air inlet side of a fan. The air duct structure includes an air inlet port, a flow-guiding cavity and an air distribution assembly. The air inlet port is configured to introduce external airflow into the air duct structure. The flow-guiding cavity is formed between the air inlet port and the air inlet side of the fan. The air distribution assembly is arranged in the flow-guiding cavity to uniformly distribute an air suction force of the air inlet port. The airflow suction force at the air inlet port is distributed more uniformly by the air distribution assembly, which effectively weakens the maximum wind speed on the shortest path.
    Type: Application
    Filed: July 19, 2023
    Publication date: April 18, 2024
    Applicant: Sungrow Hydrogen Sci. & Tech. Co., Ltd.
    Inventors: Xiangwen Ge, Yuqin Jiang, Shengwei Gong, Zhitong Zhang, Erhao Chen
  • Publication number: 20220411430
    Abstract: The disclosure relates to a series of substituted imidazolecarboxamide compounds of formula I as BTK (Bruton's Tyrosine Kinase) inhibitors, and the methods of using the same for the treatment of autoimmune disease, inflammatory disease, cancer and potentially allergies.
    Type: Application
    Filed: December 4, 2020
    Publication date: December 29, 2022
    Applicant: Henan Zhiwei Biomedicine Co., Ltd.
    Inventors: Yuqin Jiang, Qingjie Ding, Chunhua Ma, Guiqing Xu, Dandan Zhang, Yang Li, Pengfei Li, Wei Li, Shouning Yang, Xin Shi, Peipei Shi
  • Publication number: 20220259181
    Abstract: Disclosed is a compound of formula I or a pharmaceutically acceptable salt, active metabolite, tautomer, stereoisomer, or prodrug thereof as BTK (Bruton's Tyrosine Kinase) inhibitors, which is useful for the treatment of autoimmune disease, inflammatory disease, cancer and potentially allergies.
    Type: Application
    Filed: May 9, 2020
    Publication date: August 18, 2022
    Applicant: Henan Zhiwei Biomedicine Co., Ltd.
    Inventors: Qingjie Ding, Chunhua Ma, Yuqin Jiang, Guiqing Xu, Wei Li, Minghao Zhao, Qingyun Li, Dan-dan Zhang, Guojie Fan, Yang Li, Xin Shi, Shouning Yang